Analysis of partial cost with vaccine for prevention of Influenza A (H1N1)

• Autor(a) principal: Oliveira, Edmilson de
• Data de Publicação: 2014
• Outros Autores: Júnior, José Aparecido Bellucci, Inoue, Kelly Cristina, Matsuda, Laura Misue
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Vigilância Sanitária em Debate
• Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/136
• topic: Influenza Vaccines; Health Care Costs; Drug Costs; Costs and Cost Analysis; Vacinas Contra Influenza; Custos de Cuidados de Saúde; Custos de Medicamentos; Custos e Análise de Custo

This paper aimed to identify the partial cost of the vaccine against Influenza A (H1N1) in Londrina, during the year 2012. The documents contained in the Evaluation of Immu-nization Program and also from DATASUS were used as a data source. The partial cost of the vaccine was calculated taking from the product of the unit price and quantity of vaccine doses administered, based on national currency (Real). We realized that the to-tal cost of the vaccine was R$ 870,097.90, equivalent to 122,549 unit doses. The highest consumption was between the elderly and children under two years, which totaled R$ 533.366,20. To vaccinate the entire population of Londrina-PR would be necessary an amount of R$ 3.597.577,10. It was concluded that the vaccine available to the city in 2012 was sufficient to immunize the entire population of Londrina, defined by the Mi-nistry of Health and also for those categories labeled high risk. The number of vaccine administrated in children under two years and health professionals has exceeded the number of individuals of these populations identified in the city, and that the overall financial impact of vaccination would be minimal budget.